immunopathogenesis
Posted: Fri May 02, 2008 4:57 pm
.
Welcome to This is MS, the leading forum for Multiple Sclerosis research and support. Join our friendly community of patients, caregivers, and researchers celebrating over 20 years of delivering hope through knowledge.
https://www.thisisms.com/forum/
I wonder what the folks at Opexa think of a statement like that? Clearly, Opexa is able to identify myelin reactive T-cells with a specific antigen profile otherwise they would not be able to make statements like...The target antigen of the immune response has not been identified.
NHEIndividualized Tovaxin formulations for all 150 patients have been manufactured with more than 95% of them being unique myelin epitope profiles as identified by Opexa's Epitope Analysis Assay. The variety among the formulations highlights the diversity of myelin epitopes contributing to the disease and supports the individualized therapy approach of Opexa's Tovaxin therapy.